Cargando…

P2X7 Receptor Upregulation in Huntington’s Disease Brains

Huntington’s disease (HD) is a fatal degenerative disorder affecting the nervous system. It is characterized by motor, cognitive, and psychiatric dysfunctions, with a late onset and an autosomal dominant pattern of inheritance. HD-causing mutation consists in an expansion of repeated CAG triplets in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ollà, Ivana, Santos-Galindo, María, Elorza, Ainara, Lucas, José J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573237/ https://www.ncbi.nlm.nih.gov/pubmed/33122998 http://dx.doi.org/10.3389/fnmol.2020.567430

Ejemplares similares

The P2X7 Receptor: Central Hub of Brain Diseases
por: Andrejew, Roberta, et al.
Publicado: (2020)

Huntington’s disease-specific mis-splicing unveils key effector genes and altered splicing factors
por: Elorza, Ainara, et al.
Publicado: (2021)

The Role of P2X7 Receptor in Alzheimer’s Disease
por: Francistiová, Linda, et al.
Publicado: (2020)

Ubiquitin–proteasome system involvement in Huntington’s disease
por: Ortega, Zaira, et al.
Publicado: (2014)

P2X7 Receptors as a Therapeutic Target in Cerebrovascular Diseases
por: Cisneros-Mejorado, Abraham J., et al.
Publicado: (2020)

Association of Hypomorphic P2X7 Receptor Genotype With Age
por: Sanz, Juana Maria, et al.
Publicado: (2020)

Editorial: P2X7 as Common Therapeutic Target in Brain Diseases
por: Engel, Tobias, et al.
Publicado: (2021)

P2X7 Receptor-Dependent microRNA Expression Profile in the Brain Following Status Epilepticus in Mice
por: Conte, Giorgia, et al.
Publicado: (2020)

Editorial: P2X7 Receptor Function in Neurodegenerative Diseases
por: Faria, Robson Xavier, et al.
Publicado: (2021)

ATP Signaling Controlling Dyskinesia Through P2X7 Receptors
por: Fonteles, Analu A., et al.
Publicado: (2020)

Role of P2X7 Receptors in Immune Responses During Neurodegeneration
por: Oliveira-Giacomelli, Ágatha, et al.
Publicado: (2021)

Preserving cortico-striatal function: deep brain stimulation in Huntington’s disease
por: Nagel, Sean J., et al.
Publicado: (2015)

Astrocytic and Oligodendrocytic P2X7 Receptors Determine Neuronal Functions in the CNS
por: Zhao, Ya-Fei, et al.
Publicado: (2021)

Pathogenic SREK1 decrease in Huntington’s disease lowers TAF1 mimicking X-linked dystonia parkinsonism
por: Hernández, Ivó H, et al.
Publicado: (2020)

Nicotinamide Adenine Dinucleotide Phosphate Oxidases Are Everywhere in Brain Disease, but Not in Huntington’s Disease?
por: Villegas, Luisana, et al.
Publicado: (2021)

P2X2 Receptor Expression and Function Is Upregulated in the Rat Supraoptic Nucleus Stimulated Through Refeeding After Fasting
por: Ivetic, Milorad, et al.
Publicado: (2019)

Altered Levels and Isoforms of Tau and Nuclear Membrane Invaginations in Huntington’s Disease
por: Fernández-Nogales, Marta, et al.
Publicado: (2020)

A Prospective Pilot Trial for Pallidal Deep Brain Stimulation in Huntington’s Disease
por: Wojtecki, Lars, et al.
Publicado: (2015)

P2X7 Receptor Antagonism as a Potential Therapy in Amyotrophic Lateral Sclerosis
por: Ruiz-Ruiz, Cristina, et al.
Publicado: (2020)

Selective estrogen receptor modulators regulate reactive microglia after penetrating brain injury
por: Barreto, George E., et al.
Publicado: (2014)

Huntington’s Disease and Striatal Signaling
por: Roze, Emmanuel, et al.
Publicado: (2011)

Contribution of Neuroepigenetics to Huntington’s Disease
por: Francelle, Laetitia, et al.
Publicado: (2017)

Acanthocytes Identified in Huntington’s Disease
por: Yu, Yueyi, et al.
Publicado: (2022)

The ATP-Gated P2X7 Receptor As a Target for the Treatment of Drug-Resistant Epilepsy
por: Beamer, Edward, et al.
Publicado: (2017)

A Commentary on: “Preserving cortico-striatal function: Deep Brain Stimulation in Huntington's disease”
por: Tolleson, Christopher M.
Publicado: (2015)

Increased P2X7 Receptor Binding Is Associated With Neuroinflammation in Acute but Not Chronic Rodent Models for Parkinson’s Disease
por: Crabbé, Melissa, et al.
Publicado: (2019)

P2Y6 and P2X7 Receptor Antagonism Exerts Neuroprotective/ Neuroregenerative Effects in an Animal Model of Parkinson’s Disease
por: Oliveira-Giacomelli, Ágatha, et al.
Publicado: (2019)

Corticostriatal Dysfunction in Huntington’s Disease: The Basics
por: Bunner, Kendra D., et al.
Publicado: (2016)

Microglial Activation in the Pathogenesis of Huntington’s Disease
por: Yang, Hui-Ming, et al.
Publicado: (2017)

Cortical and Striatal Circuits in Huntington’s Disease
por: Blumenstock, Sonja, et al.
Publicado: (2020)

The Role of Microglia and Astrocytes in Huntington’s Disease
por: Palpagama, Thulani H., et al.
Publicado: (2019)

Altered Cholesterol Homeostasis in Huntington’s Disease
por: Kacher, Radhia, et al.
Publicado: (2022)

Cannabinoid signaling and risk in Huntington's disease
por: Humble, James, et al.
Publicado: (2022)

Commentary: Acanthocytes identified in Huntington's disease
por: Peikert, Kevin, et al.
Publicado: (2022)

Disposition of Proteins and Lipids in Synaptic Membrane Compartments Is Altered in Q175/Q7 Huntington’s Disease Mouse Striatum
por: Iuliano, Maria, et al.
Publicado: (2021)

Dynamic micro-organization of P2X7 receptors revealed by PALM based single particle tracking
por: Shrivastava, Amulya N., et al.
Publicado: (2013)

Neuronal Release of Cytokine IL-3 Triggered by Mechanosensitive Autostimulation of the P2X7 Receptor Is Neuroprotective
por: Lim, Jason C., et al.
Publicado: (2016)

P2X7 receptor-activated microglia in cortex is critical for sleep disorder under neuropathic pain
por: Li, Tingting, et al.
Publicado: (2023)

Reactive Neuroblastosis in Huntington’s Disease: A Putative Therapeutic Target for Striatal Regeneration in the Adult Brain
por: Kandasamy, Mahesh, et al.
Publicado: (2018)

ATP-gated P2X receptors in health and disease
por: Burnstock, Geoffrey, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h4s01jh111e1apj03m565t37um